Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medtronic Ends Ongoing Spinal Litigation With $1.35 Bil. IP Buy

This article was originally published in The Gray Sheet

Executive Summary

Artificial disc manufacturers may be at risk of being sued by Medtronic concerning disc-space clearing techniques and toolsets following the firm's $1.35 bil. acquisition of spine-related intellectual property

You may also be interested in...



ICD Market Lead Maintained By Medtronic; Spine/ENT Poised For Growth

Medtronic implantable cardioverter defibrillators gained market share in the firm's fiscal Q4, despite a voluntary field action in February to replace certain Marquis ICD devices

ICD Market Lead Maintained By Medtronic; Spine/ENT Poised For Growth

Medtronic implantable cardioverter defibrillators gained market share in the firm's fiscal Q4, despite a voluntary field action in February to replace certain Marquis ICD devices

Zimmer Energized About Organic Growth Opportunities In Trauma, Spine Units

Zimmer, the leading player in the hip and knee implant markets, reports promising signs of life from several of its non-reconstructive businesses

Related Content

UsernamePublicRestriction

Register

MT021990

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel